NaDeNo

Nanoligent

The company develops targeted protein-drug nanoconjugates for oncology patients to treat metastatic tumours by selectively eliminating cells overexpressing the CXCR4 receptor.

Prosemble

This biotechnology company develops an artificial intelligence and nanotechnology platform to design protein-based nanoparticle systems for precise drug delivery to cancer patients.

Disruptive Pharma

This company develops a drug formulation platform to improve the solubility and bioavailability of pharmaceutical compounds for the healthcare industry.

Cristal Therapeutics

This deep-tech company develops click chemistry reagents and nanoparticle delivery platforms for pharmaceutical and diagnostic partners in the life sciences industry.

BioSapien

This company develops 3D-printed biodegradable mesh for localized and sustained delivery of chemotherapy drugs to cancer patients.

Nanograb

This company develops an artificial intelligence platform to design targeted gene delivery vectors and nanoparticles for pharmaceutical organisations developing genetic medicines.

RS Research

This biotechnology company develops targeted nanomedicine delivery platforms and polymer-drug conjugates for oncology patients and pharmaceutical researchers.

NANOLYZE

This company develops waveguide microscopy equipment for real-time analysis of nanoparticles to support researchers in drug development and nanomedicine.